Extra-intestinal Manifestations of Shigellosis in 792 Inpatients <15 Years by Species of <i>Shigella.</i>

Values are worst (most abnormal) during hospital stay. Values are n (%). *P<0.040: S. dysenteriae type 1 versus S. boydii, S. flexneri versus S. boydii. †P<0.05: S. dysenteriae type 1 versus S. boydii; S. dysenteriae types 2–10 versus S. flexneri, S. boydii or S. sonnei. ‡Blood leukocytes data were missing for 10/157 patients in the S. dysenteriae type 1 group, 26/504 patients in the S. flexneri group, 6/77 patients in the S. boydii group, and 1/30 patient in the S. sonnei group. §.P<0.001: S. dysenteriae type 1 versus S. dysenteriae types 2–10, S. flexneri, S. boydii. ||Hematocrit data were missing for 4/157 patients in the S. dysenteriae type 1 group, 23/504 patients in the S. flexneri group, and 5/77 patients in the S. boydii group. ¶ ¶ ¶P<0.019: S. dysenteriae type 1 versus S. flexneri or S. boydii; S dysenteriae type 2–10 versus S. flexneri or S. boydii. **Serum Creatinine data were missing for 53/157 patients in the S. dysenteriae type 1 group, 9/24 patients in the S. dysenteriae types 2–10 group, 304/504 patients in the S. flexneri group, 51/77 patients in the S. boydii group, and 20/30 patients in the S. sonnei. ††P = 0.001: S. dysenteriae type 1 versus S. flexneri. ‡‡Diagnosis of hemolytic-uremic syndrome required three criteria to be met: 1) an absolute packed cell volume <20%; or 2) a decrease in absolute packed cell volume of >10% in 24 hours; or 3) ≥0.5% schistocytes on a peripheral blood; and 4) serum creratinine, >180 mmol/L. §§P<0.050: S. dysenterie type 1 vesus S. flexneri; S. flexneri versus S. sonnei. || ||Serum sodium data were missing for 9/157 patients in the S. dysenteriae type1 group, 34/504 patients in the S. flexneri group, 9/77 patients in the S. boydii group, and 2/30 patients in the S. sonnei. ¶¶P<0.001: S. dysenteriae type 1 versus S. dysenteriae type 2–10, S. flexneri, S. boydii or S. sonnei. ***Blood glucose data were missing for 121/157 patients in the S. dysenteriae type 1 group, 19/24 patients in the S. dysenteriae types 2–10 group, 402/504 patients in the S. flexneri group, 63/77 patients in the S. boydii group, and 25/30 patients in the S. sonnei group. †††Serum protein data were missing for 105/157 patients in the S. dysenteriae type 1 group, 15/24 patients in the S. dysenteriae types 2–10 group, 378/504 patients in the S. flexneri group, 52/77 patients in the S. boydii group; and 23/30 patients in the S. sonnei group. ‡‡‡P<0.035: S. dysenteriae type 1 versus S. dysenteriae types 2–10, or S. boydii. §§§Blood culture data were missing for 42/157 patients in the S. dysenteriae type 1 group, 5/24 patients in the S. dysenteriae types 2–10 group, 172/504 patients in the S. flexneri group, 32/77 patients in the S. boydii group; and 10/30 patients in the S. sonnei group.